Skip to Main Content

Anne Wyllie, PhD

Research Scientist in Epidemiology (Microbial Diseases)

Appointments

Biography

As compared to the gold standard nasopharyngeal swab, Dr. Wyllie’s work has identified saliva as a reliable sample type for the sensitive detection of Streptococcus pneumoniae (the pneumococcus) in healthy older adults and more recently, SARS-CoV-2 in persons suspected of COVID-19. Improved detection of the pneumococcus has unveiled hidden reservoirs of pneumococcus in older adults which holds importance when new vaccination strategies for preventing pneumococcal disease are being considered. For COVID-19, sampling saliva can alleviate many of the bottlenecks encountered in the mass testing strategies required to control continuing outbreaks. In an effort to address many of these issues, Wyllie further validated and optimized saliva for SARS-CoV-2 detection and developed SalivaDirect: a simple, scalable and importantly, cost-effective method to help alleviate SARS-CoV-2 testing demands.

Education & Training

  • PhD
    Utrecht University, Medical Microbiology (2016)
  • MBioMedSci
    University of Auckland, Cancer Immunology (2009)
  • BMedSci
    University of Auckland, Immunology and Microbiology (2007)

Honors & Recognition

AwardAwarding OrganizationDate
COVID-19 Research AwardYale School of Public Health2021
Medal of ExcellenceNorthcote College Board of Trustees2020

Departments & Organizations